Loading…
Based on limited metadata, the FDA issued a Warning Letter to Predictive Biotech, a company involved in drug development or manufacturing, on August 17, 2020. Without access to the full letter text or subject line, the specific regulatory violations cannot be detailed; however, the warning indicates non-compliance with FDA drug manufacturing or marketing standards. The letter was issued under FDA authority governing drug products, though the specific issuing office is not identified in the available metadata. This summary is preliminary and should be supplemented with the complete Warning Letter for comprehensive regulatory analysis.